Whitepaper: 2021 Outlook for Value-Based Care and the Self-Insured Employer Marketplace

May 2021

Numerous efforts to transition the U.S. healthcare system to a value-based care construct have been attempted during the past couple decades, including top-down initiatives such as accountable care organizations, with mixed results. However, bright spots can be found, including bottom-up initiatives that are transforming pockets of the healthcare landscape. In particular, value-based care is gaining momentum in the evolving self-insured employer ecosystem.

Employer self-funded healthcare plans continue to grow in popularity, with over 100 million people in the United States now covered by these plans. However, in this era of value-based care, most self-insured plans are underequipped with tools and technologies to effectively engage employees, manage costs, and provide value to employees and employers. Efforts to advance value-based care for the self-insured employer marketplace are leading to numerous investment opportunities in services, technologies, and care providers.

During a recent event, panelists from Lincoln International, Stax Inc. and Farragut Square Group with relevant experience in the space provided an overview of the self-insured employer marketplace, described current trends and highlighted areas with attractive investment opportunities. They also summarized what they look for in conducting diligence about possible investments in these areas. Complete the form below to receive a white paper which both summarizes key topics discussed at the event and explores key data on the value-based care marketplace.

Please complete the form below to receive a copy of the white paper:



Summary

  • On Thursday, March 18, 2021, experts from Lincoln International's Healthcare Group joined Farragut Square Group's webinar to discuss value-based care and the self-insured employer market.

  • Sign up to receive Lincoln's perspectives

Contributors

Meet Professionals with Complementary Expertise

Related Perspectives

In Vivo Pharma Intelligence | The Growth Path for Drug Discovery Partners

Originally published by In Vivo Pharma Intelligence on November 15, 2022 James West, Director in Lincoln’s Healthcare Group, explains the key trends and mergers and acquisitions (M&A) dynamics in the… Read More

Lincoln’s Latest

In Q3 2020, Lincoln International introduced Lincoln’s Latest video series. Experts from across industries, services and geographies, share perspectives on current trends, recent observations and future outlooks through this video… Read More

Surging Medical Inflation Fuels Continued Interest in Self-Funding and Cost Containment

During the past 18 months, inflation has accelerated to levels not seen since the early 1980s. The cost of energy, food and other staples has increased rapidly and is expected… Read More

Lincoln International Expands Presence to Southeast, Opening Miami and Atlanta Offices

Continued growth spurs openings in new geographies for both client coverage and talent acquisition Lincoln International announced today that it has expanded its U.S. footprint with the opening of offices… Read More